Other Species / Isoforms
  BCDIN3 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

  HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
K21-sm
PAPPPPLkDESGGGG
0 1
BCDIN3 (human) PAPPPPLkDESGGGG K21-sm
BCDIN3 (mouse) PAPPPPLKDEsGGGG K21
BCDIN3 (rat) PAPPPPLKDESGGGG K21
BCDIN3 (cow) PAPPPPLKDESGGGG K21
S24
PPPLkDESGGGGGPT
0 2
BCDIN3 (human) PPPLkDESGGGGGPT S24
BCDIN3 (mouse) PPPLKDEsGGGGGPE S24-p
BCDIN3 (rat) PPPLKDESGGGGGPE S24
BCDIN3 (cow) PPPLKDESGGGGGPT S24
S57-p
GPGRCAPsAGsPAAA
0 4
BCDIN3 (human) GPGRCAPsAGsPAAA S57-p
BCDIN3 (mouse) GPGPRAHSAGAAASG S57
BCDIN3 (rat) GPGPRAHSAGATASG S57
BCDIN3 (cow) APGPRAHSAGSPASG S57
S60-p
RCAPsAGsPAAAVGR
0 31
BCDIN3 (human) RCAPsAGsPAAAVGR S60-p
BCDIN3 (mouse) gap -
BCDIN3 (rat) gap -
BCDIN3 (cow) PRAHSAGSPASGAGK S60
S69-p
AAAVGREsPGAAATS
Upstream
0 38
Treatment
  • nocodazole
  • ZK-Thiazolidinone
BCDIN3 (human) AAAVGREsPGAAATS S69-p
BCDIN3 (mouse) gap -
BCDIN3 (rat) gap -
BCDIN3 (cow) ASGAGKESPGAASTP S69
S78-p
GAAATSSsGPQAQQH
0 3
BCDIN3 (human) GAAATSSsGPQAQQH S78-p
BCDIN3 (mouse) gap -
BCDIN3 (rat) gap -
BCDIN3 (cow) GAASTPRGGQSQQQQ G78
R86-m1
GPQAQQHrGGGPQAQ
Upstream
0 2
Treatment
  • actinomycin_D
BCDIN3 (human) GPQAQQHrGGGPQAQ R86-m1
BCDIN3 (mouse) gap -
BCDIN3 (rat) gap -
BCDIN3 (cow) GQSQQQQRGGGPQAQ R86
S94-p
GGGPQAQsHGEARLs
0 1
BCDIN3 (human) GGGPQAQsHGEARLs S94-p
BCDIN3 (mouse) GGGPQAQAHGEPHGR A72
BCDIN3 (rat) GGGPQAQTHGEPHGR T72
BCDIN3 (cow) GGGPQAQSHGEACLS S94
S101-p
sHGEARLsDPPGRAA
Upstream
0 12
Treatment
  • ischemia
  • ZK-Thiazolidinone
BCDIN3 (human) sHGEARLsDPPGRAA S101-p
BCDIN3 (mouse) gap -
BCDIN3 (rat) gap -
BCDIN3 (cow) SHGEACLSDPHGRAA S101
R117-m1
PDVGEERrGGGGTEL
0 3
BCDIN3 (human) PDVGEERrGGGGTEL R117-m1
BCDIN3 (mouse) ADVGEERrGGGGTDL R91-m1
BCDIN3 (rat) ADVGEERRGGGGTDL R91
BCDIN3 (cow) PDVGEERRGGGGTEL R117
K148-ac
PPGGGGGkRRNsCNV
0 12
BCDIN3 (human) PPGGGGGkRRNsCNV K148-ac
BCDIN3 (mouse) PPGGGGGkRRNsCNV K122-ac
BCDIN3 (rat) PPVGGGGKRRNsCNV K122
BCDIN3 (cow) PPGGGGGKRRNSCHV K148
S152-p
GGGkRRNsCNVGGGG
Upstream
0 44
Treatment
  • ischemia
BCDIN3 (human) GGGkRRNsCNVGGGG S152-p
BCDIN3 (mouse) GGGkRRNsCNVGGGS S126-p
BCDIN3 (rat) GGGKRRNsCNVGGGS S126-p
BCDIN3 (cow) GGGKRRNSCHVGGGG S152
-
gap
0 1
BCDIN3 (human) gap -
BCDIN3 (mouse) VGGGSGGsFKHPAFK S136-p
BCDIN3 (rat) VGGGSGGSFKHPAFK S136
BCDIN3 (cow) gap -
K163-ub
GGGGGGFkHPAFKRR
0 1
BCDIN3 (human) GGGGGGFkHPAFKRR K163-ub
BCDIN3 (mouse) GGSGGsFKHPAFKRR K138
BCDIN3 (rat) GGSGGSFKHPAFKRR K138
BCDIN3 (cow) GGGGGGFKHPAFKRR K163
S175-p
KRRRRVNsDCDsVLP
Upstream
0 95
Treatment
  • gefitinib
  • rapamycin
  • U0126
  • wortmannin
view more >
BCDIN3 (human) KRRRRVNsDCDsVLP S175-p
BCDIN3 (mouse) KRRRRVNsDCDsVLP S150-p
BCDIN3 (rat) KRRRRVNsDCDSVLP S150-p
BCDIN3 (cow) KRRRRVNSDCDSVLP S175
S179-p
RVNsDCDsVLPsNFL
Upstream
0 15
Treatment
  • EGF
BCDIN3 (human) RVNsDCDsVLPsNFL S179-p
BCDIN3 (mouse) RVNsDCDsVLPSNFL S154-p
BCDIN3 (rat) RVNsDCDSVLPSNFL S154
BCDIN3 (cow) RVNSDCDSVLPSNFL S179
S183-p
DCDsVLPsNFLLGGN
0 1
BCDIN3 (human) DCDsVLPsNFLLGGN S183-p
BCDIN3 (mouse) DCDsVLPSNFLLGGN S158
BCDIN3 (rat) DCDSVLPSNFLLGGN S158
BCDIN3 (cow) DCDSVLPSNFLLGGN S183
S199
FDPLNLNSLLDEEVS
0 1
BCDIN3 (human) FDPLNLNSLLDEEVS S199
BCDIN3 (mouse) FDPLNLNsLLDEEVS S174-p
BCDIN3 (rat) FDPLNLNSLLDEEVS S174
BCDIN3 (cow) FDPLNLNSLLDEEVS S199
T208-p
LDEEVSRtLNAEtPK
0 9
BCDIN3 (human) LDEEVSRtLNAEtPK T208-p
BCDIN3 (mouse) LDEEVSRALNAEtPK A183
BCDIN3 (rat) LDEEVSRALNAEtPK A183
BCDIN3 (cow) LDEEVSRALNAETPK A208
T213-p
SRtLNAEtPKssPLP
Upstream
0 148
Regulatory protein:
  • PRP4 (human)
  • TBK1 (human)
Treatment
  • ischemia
  • LRRK2-IN-1
  • nocodazole
  • ZK-Thiazolidinone
view more >
BCDIN3 (human) SRtLNAEtPKssPLP T213-p
BCDIN3 (mouse) SRALNAEtPKssPLP T188-p
BCDIN3 (rat) SRALNAEtPKsSPLP T188-p
BCDIN3 (cow) SRALNAETPKSSPLP T213
S216-p
LNAEtPKssPLPAkG
Upstream
0 113
Regulatory protein:
  • PRP4 (human)
Treatment
  • nocodazole
BCDIN3 (human) LNAEtPKssPLPAkG S216-p
BCDIN3 (mouse) LNAEtPKssPLPAKG S191-p
BCDIN3 (rat) LNAEtPKsSPLPAKG S191-p
BCDIN3 (cow) LNAETPKSSPLPAKG S216
S217-p
NAEtPKssPLPAkGR
Upstream
0 63
Treatment
  • EGF
  • ischemia
  • nocodazole
  • ZK-Thiazolidinone
view more >
BCDIN3 (human) NAEtPKssPLPAkGR S217-p
BCDIN3 (mouse) NAEtPKssPLPAKGR S192-p
BCDIN3 (rat) NAEtPKsSPLPAKGR S192
BCDIN3 (cow) NAETPKSSPLPAKGR S217
K222-ub
KssPLPAkGRDPVEI
0 1
BCDIN3 (human) KssPLPAkGRDPVEI K222-ub
BCDIN3 (mouse) KssPLPAKGRDPVEI K197
BCDIN3 (rat) KsSPLPAKGRDPVEI K197
BCDIN3 (cow) KSSPLPAKGRDPVEI K222
K233-ub
PVEILIPkDITDPLs
0 1
BCDIN3 (human) PVEILIPkDITDPLs K233-ub
BCDIN3 (mouse) PVEILIPKDITDPLS K208
BCDIN3 (rat) PVEILIPKDITDPLS K208
BCDIN3 (cow) PVEILIPKDITDPLS K233
S240-p
kDITDPLsLNtCTDE
0 2
BCDIN3 (human) kDITDPLsLNtCTDE S240-p
BCDIN3 (mouse) KDITDPLSLNTCTDE S215
BCDIN3 (rat) KDITDPLSLNTCTDE S215
BCDIN3 (cow) KDITDPLSLNTCTDE S240
T243-p
TDPLsLNtCTDEGHV
0 2
BCDIN3 (human) TDPLsLNtCTDEGHV T243-p
BCDIN3 (mouse) TDPLSLNTCTDEAHV T218
BCDIN3 (rat) TDPLSLNTCTDEAHV T218
BCDIN3 (cow) TDPLSLNTCTDEAQV T243
S254-p
EGHVVLAsPLktGRK
Upstream
0 46
Treatment
  • nocodazole
  • Y27632
BCDIN3 (human) EGHVVLAsPLktGRK S254-p
BCDIN3 (mouse) EAHVVLAsPLKIGRK S229-p
BCDIN3 (rat) EAHVVLASPLKIGRK S229
BCDIN3 (cow) EAQVVLASPLKTGRK S254
K257-ub
VVLAsPLktGRKRHR
0 1
BCDIN3 (human) VVLAsPLktGRKRHR K257-ub
BCDIN3 (mouse) VVLAsPLKIGRKRHR K232
BCDIN3 (rat) VVLASPLKIGRKRHR K232
BCDIN3 (cow) VVLASPLKTGRKRHR K257
T258-p
VLAsPLktGRKRHRH
0 14
BCDIN3 (human) VLAsPLktGRKRHRH T258-p
BCDIN3 (mouse) VLAsPLKIGRKRHRH I233
BCDIN3 (rat) VLASPLKIGRKRHRH I233
BCDIN3 (cow) VLASPLKTGRKRHRH T258
R266-m1
GRKRHRHrGQHHQQQ
0 1
BCDIN3 (human) GRKRHRHrGQHHQQQ R266-m1
BCDIN3 (mouse) GRKRHRHRGPHHQQQ R241
BCDIN3 (rat) GRKRHRHRGPHHQQQ R241
BCDIN3 (cow) GRKRHRHRGQHHHQQ R266
T287-p
ESHPVPPtAPLtPLL
0 1
BCDIN3 (human) ESHPVPPtAPLtPLL T287-p
BCDIN3 (mouse) SNAAVLPTDPLtPSL T264
BCDIN3 (rat) DSQAVLPTDPLTPSV T262
BCDIN3 (cow) DSHSALPTTPLTSSL T288
T291-p
VPPtAPLtPLLHGEG
Upstream
0 72
Treatment
  • nocodazole
BCDIN3 (human) VPPtAPLtPLLHGEG T291-p
BCDIN3 (mouse) VLPTDPLtPSLHGEG T268-p
BCDIN3 (rat) VLPTDPLTPSVHGEG T266
BCDIN3 (cow) ALPTTPLTSSLHGEG T292
S300-p
LLHGEGAsQQPrHRG
0 8
BCDIN3 (human) LLHGEGAsQQPrHRG S300-p
BCDIN3 (mouse) SLHGEGATQQQQNRG T277
BCDIN3 (rat) SVHGEGATQQHRGQN T275
BCDIN3 (cow) SLHGEGTTQQHGGQN T301
R304-m1
EGAsQQPrHRGQNRD
0 1
BCDIN3 (human) EGAsQQPrHRGQNRD R304-m1
BCDIN3 (mouse) EGATQQQQNRGQNRD Q281
BCDIN3 (rat) gap -
BCDIN3 (cow) gap -
Y316-p
NRDAPQPyELNTAIN
0 2
BCDIN3 (human) NRDAPQPyELNTAIN Y316-p
BCDIN3 (mouse) NRDAPQPYELNTAIN Y293
BCDIN3 (rat) NRDDPQPYELNTAIN Y289
BCDIN3 (cow) NRDAPQPYELNTAIN Y315
S330-p
NCRDEVVsPLPsALQ
Upstream
0 15
Treatment
  • nocodazole
BCDIN3 (human) NCRDEVVsPLPsALQ S330-p
BCDIN3 (mouse) NCRDEVVsPLPSALQ S307-p
BCDIN3 (rat) NCRDEVVsPLPSALQ S303-p
BCDIN3 (cow) NCRDEVVSPLPSALQ S329
S334-p
EVVsPLPsALQGPSG
0 1
BCDIN3 (human) EVVsPLPsALQGPSG S334-p
BCDIN3 (mouse) EVVsPLPSALQGSSG S311
BCDIN3 (rat) EVVsPLPSALQGSSG S307
BCDIN3 (cow) EVVSPLPSALQGPSG S333
S344-p
QGPSGSLsAPPAASV
0 1
BCDIN3 (human) QGPSGSLsAPPAASV S344-p
BCDIN3 (mouse) QGSSGSLSAPPAASV S321
BCDIN3 (rat) QGSSGSLSAPPAASV S317
BCDIN3 (cow) QGPSGSLSAPPAASV S343
S358-p
VISAPPSsSSRHRKR
0 1
BCDIN3 (human) VISAPPSsSSRHRKR S358-p
BCDIN3 (mouse) TSAPSTSSSSRHRKR S336
BCDIN3 (rat) VTSAPSSSSSRHRKR S331
BCDIN3 (cow) VTSAPPSSSSRHRKR S357
S369-p
HRKRRRTsSKSEAGA
0 2
BCDIN3 (human) HRKRRRTsSKSEAGA S369-p
BCDIN3 (mouse) HRKRRRTsSKSEAGA S347-p
BCDIN3 (rat) HRKRRRTSSKSEAGA S342
BCDIN3 (cow) HRKRRRTSSKSEAGA S368
R377-m1
SKSEAGArGGGQGSk
0 14
BCDIN3 (human) SKSEAGArGGGQGSk R377-m1
BCDIN3 (mouse) SKSEAGARGGSQGSK R355
BCDIN3 (rat) SKSEAGARGGSQGSK R350
BCDIN3 (cow) SKSEAGARGGGQGSK R376
K384-m1
rGGGQGSkEKGRGsW
0 1
BCDIN3 (human) rGGGQGSkEKGRGsW K384-m1
BCDIN3 (mouse) RGGSQGSKEKGRGSG K362
BCDIN3 (rat) RGGSQGSKEKGRGSG K357
BCDIN3 (cow) RGGGQGSKEKGRGSG K383
S390-p
SkEKGRGsWGGRHHH
Upstream
0 8
Treatment
  • BI_4834
  • nocodazole
BCDIN3 (human) SkEKGRGsWGGRHHH S390-p
BCDIN3 (mouse) SKEKGRGSGGGRHHH S368
BCDIN3 (rat) SKEKGRGSGGGRHHH S363
BCDIN3 (cow) SKEKGRGSGGGRHHL S389
K412-ub
GFKKQQRkFQYGNyC
0 1
BCDIN3 (human) GFKKQQRkFQYGNyC K412-ub
BCDIN3 (mouse) GFKKQQLKFQYGNYC K389
BCDIN3 (rat) GFKKQQLKFQYGNYC K383
BCDIN3 (cow) TFKKQQCKFQYGNYC K410
Y418-p
RkFQYGNyCKYYGYR
0 2
BCDIN3 (human) RkFQYGNyCKYYGYR Y418-p
BCDIN3 (mouse) LKFQYGNYCKYYGYR Y395
BCDIN3 (rat) LKFQYGNYCKYYGYR Y389
BCDIN3 (cow) CKFQYGNYCKYYGYR Y416
K438-ub
DGRLRVLkPEWFRGR
0 1
BCDIN3 (human) DGRLRVLkPEWFRGR K438-ub
BCDIN3 (mouse) DVRLRVLKPEWFQGR K415
BCDIN3 (rat) DMRLRVLKPEWFQGR K409
BCDIN3 (cow) DGRLRVLKPEWFRGR K436
L502
LRLPPQTLEGDPGAE
0 1
BCDIN3 (human) LRLPPQTLEGDPGAE L502
BCDIN3 (mouse) LRLQAQTsEGDPGtE S479-p
BCDIN3 (rat) LRLQAQTSEGDPGTE S473
BCDIN3 (cow) LRLPPQTSEGSPGAE S500
A508
TLEGDPGAEGEEGTT
0 2
BCDIN3 (human) TLEGDPGAEGEEGTT A508
BCDIN3 (mouse) TsEGDPGtEGEEGTI T485-p
BCDIN3 (rat) TSEGDPGTEGEEGTT T479
BCDIN3 (cow) TSEGSPGAESEEGTT A506
K627-ub
WSSYGKRktLTETIY
0 1
BCDIN3 (human) WSSYGKRktLTETIY K627-ub
BCDIN3 (mouse) WSSYCKRKsLTETIY K604
BCDIN3 (rat) WSSYCRRKSLTETIY K598
BCDIN3 (cow) WSSYGRRKTLTERIY K625
T628-p
SSYGKRktLTETIYk
0 2
BCDIN3 (human) SSYGKRktLTETIYk T628-p
BCDIN3 (mouse) SSYCKRKsLTETIYK S605-p
BCDIN3 (rat) SSYCRRKSLTETIYK S599
BCDIN3 (cow) SSYGRRKTLTERIYK T626
K635-ub
tLTETIYkNYYRIQL
0 4
BCDIN3 (human) tLTETIYkNYYRIQL K635-ub
BCDIN3 (mouse) sLTETIYKNYFRIQL K612
BCDIN3 (rat) SLTETIYKNYFRIQL K606
BCDIN3 (cow) TLTERIYKNYFRIQL K633
Y661-p
PDVGFSSyELVATPH
0 8
BCDIN3 (human) PDVGFSSyELVATPH Y661-p
BCDIN3 (mouse) PEVGFSSYELVATPN Y638
BCDIN3 (rat) PEVGFSSYELVATPS Y632
BCDIN3 (cow) PEVGFSSYELVATPN Y659